Cargando…

An open labeled, randomized, controlled clinical study to evaluate the efficacy of Torchnil capsules and Febcin tablet as add-on therapy for Covid-19 patients

OBJECTIVES: This study was conducted to evaluate the efficacy and safety of Cap. Torchnil & Tab. Febcin when given as add-on therapy to Covid19 positive patients with moderate disease. MATERIAL AND METHODS: Following written informed consent, patients were randomized to receive Cap. Torchnil &am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munshi, Renuka, Kumbhar, Dipti, Pawaskar, Pranesh, Rajadakshya, Girish, Palep, H.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866077/ https://www.ncbi.nlm.nih.gov/pubmed/35228783 http://dx.doi.org/10.1016/j.jaim.2022.100559

Ejemplares similares

A survey of the labeling information provided for ayurvedic drugs marketed in India
por: Bhalerao, Supriya, et al.
Publicado: (2010)

A randomized, controlled, comparative, proof-of-concept study to evaluate the efficacy and safety of Nisha-Amalaki capsules in prediabetic patients for preventing progression to diabetes
por: Munshi, Renuka, et al.
Publicado: (2023)

Does Panchatikta ghrita have anti-osteoporotic effect? Assessment in an experimental model in ovariectomized rats
por: Munshi, Renuka, et al.
Publicado: (2021)

Open-label, add-on trial of cetirizine for neuromyelitis optica
por: Katz Sand, Ilana, et al.
Publicado: (2018)

The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial
por: Yan, Zhimin, et al.
Publicado: (2016)

Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010)

Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study
por: Trivedi, Ashit, et al.
Publicado: (2022)

First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Immunological & metabolic responses to a therapeutic course of Basti in obesity
por: Thatte, Urmila, et al.
Publicado: (2015)

A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2022)

An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation
por: Munshi, Renuka, et al.
Publicado: (2011)

Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial
por: Mohammadi, Tayebeh, et al.
Publicado: (2023)

An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients
por: Carta, Mauro Giovanni, et al.
Publicado: (2006)

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial
por: Shirayama, Yukihiko, et al.
Publicado: (2014)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

The amount of liquid patients use to take tablets or capsules
por: Fuchs, Joerg
Publicado: (2009)

The Use of Capsule Endoscopy to Determine Tablet Disintegration In Vivo
por: Blaabjerg, Lasse I., et al.
Publicado: (2020)

Comparative phase I randomized open-label pilot clinical trial of Gynophilus(®) (Lcr regenerans(®)) immediate release capsules versus slow release muco-adhesive tablets
por: Dausset, Caroline, et al.
Publicado: (2018)

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans
por: Chen, Yu-Luan, et al.
Publicado: (2023)

Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study
por: D'Onofrio, Gianluca, et al.
Publicado: (2020)

A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
por: Rathi, Niraj, et al.
Publicado: (2018)

Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder
por: Berlant, Jeffrey L
Publicado: (2004)

Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study
por: Sagduyu, Kemal, et al.
Publicado: (2005)

Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
por: Kim, Jong-Min, et al.
Publicado: (2015)

An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain
por: Hutchins, Jacob L, et al.
Publicado: (2018)

Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study
por: Okuda, Darin T, et al.
Publicado: (2023)

Evaluation of the efficacy and safety of conversion from the tacrolimus capsule to tablet in stable liver transplant recipients with maintenance therapy: a 24-week, open-label, single-center, phase IV exploratory clinical study
por: Kim, Jae-Yoon, et al.
Publicado: (2023)

Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study
por: Nikaido, Takuya, et al.
Publicado: (2022)

Just Add Water: Modulating the Structure-Derived Acidity of Catalytic Hexameric Resorcinarene Capsules
por: Poole, David A., et al.
Publicado: (2021)

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation
por: van Rossem, Koen, et al.
Publicado: (2013)

Effect of Sertraline as an Add-on Therapy in T2DM Patients with Comorbid Depression: An Open Label Randomized Controlled Trial
por: Kumar, Padala R., et al.
Publicado: (2019)

In situ coating makes it easier for children to swallow and tolerate tablets and capsules
por: El Edelbi, R, et al.
Publicado: (2015)

Levothyroxine Tablet Malabsorption Associated with Gastroparesis Corrected with Gelatin Capsule Formulation
por: Reardon, David P., et al.
Publicado: (2016)

Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer
por: Ninomiya, Sahoko, et al.
Publicado: (2019)

Sensory evaluation of edoxaban orally disintegrating tablets: an open-label interventional study (secondary publication)
por: Yamashita, Takeshi, et al.
Publicado: (2019)

Efficacy and Safety of Runzao Zhiyang Capsule as an Add-On Therapy for Chronic Eczema: A Systematic Review and Meta-Analysis
por: Li, Ming, et al.
Publicado: (2021)

Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
por: Gong, Xiaowei, et al.
Publicado: (2021)

MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2023)

Correction to: Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study
por: Nikaido, Takuya, et al.
Publicado: (2022)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v9r9d7klrhcl7rmpa9ehccllk3